Drug Maker Pfizer
- All
- News
- Videos
-
Pfizer Names Meenakshi Nevatia As Managing Director
Drug maker Pfizer Ltd on Thursday said it has appointed Meenakshi Nevatia as managing director for a period of five years with effect from April 3, 2023.
-
No Big Correction Ahead, Say Analysts As Sensex Scales New Peak
US-based drug maker Pfizer's statement on Monday that its experimental COVID-19 vaccine showed over 90 per cent effectiveness based on initial trial results boosted global market sentiment.
-
Pfizer Withdraws Corex Syrup, Extends Line To New Products
Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ailments as part of a revamp of its product portfolio.
-
Pfizer Concludes Rs 110-Crore Deal With Piramal Enterprises
Drug maker Pfizer on Monday said it has completed the process of transferring four products to Mumbai-based Piramal Enterprises after getting necessary regulatory approvals.
-
Pfizer Abandons Plan To Split Into Two
US drug maker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines.
-
Cipla, Wockhardt, Other Drug Makers Pledge To Clean Up Antibiotic Factories
Thirteen leading drug makers promised on Tuesday to clean up pollution from factories making antibiotics and take steps to curb overuse of the medicines as part of a drive to fight the rise of drug-resistant superbugs.
-
European Advisory Panel Recommends Nod For Pfizer Breast Cancer Drug
US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
-
Advent, Baxter Set To Submit Bids For India's Gland Pharma: Report
Global buyout firm Advent International and U.S.-based Baxter International are among suitors preparing to submit separate bids to buy unlisted Indian drugmaker Gland Pharma Ltd, three people with direct knowledge of the matter told Reuters.
-
Pfizer, Allergan Scrap $160-Billion 'Inversion' Deal
US drug maker Pfizer Inc and Ireland-based Allergan Plc formally announced the scrapping of their $160 billion merger on Wednesday, in a big win for President Barack Obama who has been pushing to curb tax-slashing "inversion" deals.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Pfizer Set to Buy Allergan in Largest Deal Ever in Healthcare Sector: Report
Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, creating the world's biggest drug maker, according to people familiar with the matter.
-
Pfizer Q4 Profit Slips on Loss of Drug Patent Exclusivity
Pfizer reported on Tuesday that revenues and profits fell again in the fourth quarter of 2014 as the drug maker continued to suffer from the loss of exclusive rights to various treatments.
-
Bayer Fails to Block Generic Cancer Drug in Supreme Court
German drug maker Bayer has failed in a last-ditch attempt to block the sale of a cheap generic version of its cancer drug Nexavar in India, after the Supreme Court ruled against it on Friday.
-
Pfizer's $11-Billion Buyback Plan Deflates AstraZeneca Bid Hopes
US drug maker Pfizer is to continue buying back stock, with the board authorising a new $11-billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca.
-
Price Cap: Drug Makers' Profitability May Come Under Pressure, Says Icra
With the drug price control order (DPCO) coverage extending to almost 40 per cent of the industry, profitability in the domestic business of pharma companies is likely to come under pressure, according to rating agency Icra.
-
Pfizer Names Meenakshi Nevatia As Managing Director
Drug maker Pfizer Ltd on Thursday said it has appointed Meenakshi Nevatia as managing director for a period of five years with effect from April 3, 2023.
-
No Big Correction Ahead, Say Analysts As Sensex Scales New Peak
US-based drug maker Pfizer's statement on Monday that its experimental COVID-19 vaccine showed over 90 per cent effectiveness based on initial trial results boosted global market sentiment.
-
Pfizer Withdraws Corex Syrup, Extends Line To New Products
Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ailments as part of a revamp of its product portfolio.
-
Pfizer Concludes Rs 110-Crore Deal With Piramal Enterprises
Drug maker Pfizer on Monday said it has completed the process of transferring four products to Mumbai-based Piramal Enterprises after getting necessary regulatory approvals.
-
Pfizer Abandons Plan To Split Into Two
US drug maker Pfizer Inc said on Monday it had decided not to separate into two publicly traded companies by separating its low-growth generics from its patent-protected branded medicines.
-
Cipla, Wockhardt, Other Drug Makers Pledge To Clean Up Antibiotic Factories
Thirteen leading drug makers promised on Tuesday to clean up pollution from factories making antibiotics and take steps to curb overuse of the medicines as part of a drive to fight the rise of drug-resistant superbugs.
-
European Advisory Panel Recommends Nod For Pfizer Breast Cancer Drug
US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
-
Advent, Baxter Set To Submit Bids For India's Gland Pharma: Report
Global buyout firm Advent International and U.S.-based Baxter International are among suitors preparing to submit separate bids to buy unlisted Indian drugmaker Gland Pharma Ltd, three people with direct knowledge of the matter told Reuters.
-
Pfizer, Allergan Scrap $160-Billion 'Inversion' Deal
US drug maker Pfizer Inc and Ireland-based Allergan Plc formally announced the scrapping of their $160 billion merger on Wednesday, in a big win for President Barack Obama who has been pushing to curb tax-slashing "inversion" deals.
-
Pfizer, Allergan Combining in $160 Billion Deal to Become Largest Drugmaker
Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
-
Pfizer Set to Buy Allergan in Largest Deal Ever in Healthcare Sector: Report
Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, creating the world's biggest drug maker, according to people familiar with the matter.
-
Pfizer Q4 Profit Slips on Loss of Drug Patent Exclusivity
Pfizer reported on Tuesday that revenues and profits fell again in the fourth quarter of 2014 as the drug maker continued to suffer from the loss of exclusive rights to various treatments.
-
Bayer Fails to Block Generic Cancer Drug in Supreme Court
German drug maker Bayer has failed in a last-ditch attempt to block the sale of a cheap generic version of its cancer drug Nexavar in India, after the Supreme Court ruled against it on Friday.
-
Pfizer's $11-Billion Buyback Plan Deflates AstraZeneca Bid Hopes
US drug maker Pfizer is to continue buying back stock, with the board authorising a new $11-billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca.
-
Price Cap: Drug Makers' Profitability May Come Under Pressure, Says Icra
With the drug price control order (DPCO) coverage extending to almost 40 per cent of the industry, profitability in the domestic business of pharma companies is likely to come under pressure, according to rating agency Icra.
